Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
To explore the significance of immune host status during EBV-associated oncogenesis, analyses of EBV-microRNAs expression, latent gene expression and EBV copy number were performed using 90 cases of EBV-related tumors. EBV-microRNA expression and copy numbers were high in the relatively immunocompetent hosts. In addition, EBV-microRNA expression was higher in lymphoproliferative disorders than in monomorphic malignant lymphomas, suggesting the significance of EBV-microRNA in early stage of oncogenesis.
|